Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

B. Ylstra; M. Cordes; H. D. Biesma; H. M. Verheul; M. Neerincx; M. Koopman; C. J. Punt; G. A. Meijers; V. Murphy; A. Barat; J. Betge; M. Ebert; T. Gaiser; B. Fender; R. Klinger; S. Das; D. Smeets; D. Lambrechts; A. T. Byrne; N. C. T. Van Grieken

doi:10.1016/S0959-8049(16)32666-1

Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

B. Ylstra, M. Cordes, H. D. Biesma, H. M. Verheul, M. Neerincx, M. Koopman, C. J. Punt, G. A. Meijers, V. Murphy, A. Barat, J. Betge, M. Ebert, T. Gaiser, B. Fender, R. Klinger, S. Das, D. Smeets, D. Lambrechts, A. T. Byrne, N. C. T. Van Grieken

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	S29-S29
Journal	European Journal of Cancer
Volume	68
Issue number	Suppl. 1
DOIs	https://doi.org/10.1016/S0959-8049(16)32666-1
Publication status	Published - Dec 2016

Access to Document

10.1016/S0959-8049(16)32666-1

Cite this

Ylstra, B., Cordes, M., Biesma, H. D., Verheul, H. M., Neerincx, M., Koopman, M., Punt, C. J., Meijers, G. A., Murphy, V., Barat, A., Betge, J., Ebert, M., Gaiser, T., Fender, B., Klinger, R., Das, S., Smeets, D., Lambrechts, D., Byrne, A. T., & Van Grieken, N. C. T. (2016). Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. European Journal of Cancer, 68(Suppl. 1), S29-S29. https://doi.org/10.1016/S0959-8049(16)32666-1

@article{68bd2edc66b8459c80f23a4cb7e039f7,

title = "Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer",

author = "B. Ylstra and M. Cordes and Biesma, {H. D.} and Verheul, {H. M.} and M. Neerincx and M. Koopman and Punt, {C. J.} and Meijers, {G. A.} and V. Murphy and A. Barat and J. Betge and M. Ebert and T. Gaiser and B. Fender and R. Klinger and S. Das and D. Smeets and D. Lambrechts and Byrne, {A. T.} and {Van Grieken}, {N. C. T.}",

note = "28 EORTC – NCI – AACR Symposium on Molecular Targets and Cancer Therapeutics 29 November 2016 - 02 December 2016",

year = "2016",

month = dec,

doi = "10.1016/S0959-8049(16)32666-1",

language = "English",

volume = "68",

pages = "S29--S29",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "Suppl. 1",

}

Ylstra, B, Cordes, M, Biesma, HD, Verheul, HM, Neerincx, M, Koopman, M, Punt, CJ, Meijers, GA, Murphy, V, Barat, A, Betge, J, Ebert, M, Gaiser, T, Fender, B, Klinger, R, Das, S, Smeets, D, Lambrechts, D, Byrne, AT & Van Grieken, NCT 2016, 'Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer', European Journal of Cancer, vol. 68, no. Suppl. 1, pp. S29-S29. https://doi.org/10.1016/S0959-8049(16)32666-1

TY - JOUR

T1 - Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

AU - Ylstra, B.

AU - Cordes, M.

AU - Biesma, H. D.

AU - Verheul, H. M.

AU - Neerincx, M.

AU - Koopman, M.

AU - Punt, C. J.

AU - Meijers, G. A.

AU - Murphy, V.

AU - Barat, A.

AU - Betge, J.

AU - Ebert, M.

AU - Gaiser, T.

AU - Fender, B.

AU - Klinger, R.

AU - Das, S.

AU - Smeets, D.

AU - Lambrechts, D.

AU - Byrne, A. T.

AU - Van Grieken, N. C. T.

N1 - 28 EORTC – NCI – AACR Symposium on Molecular Targets and Cancer Therapeutics 29 November 2016 - 02 December 2016

PY - 2016/12

Y1 - 2016/12

U2 - 10.1016/S0959-8049(16)32666-1

DO - 10.1016/S0959-8049(16)32666-1

M3 - Meeting Abstract

SN - 0959-8049

VL - 68

SP - S29-S29

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - Suppl. 1

ER -